Chapter

Clinical management of vascular and soft tissue calcifications in chronic kidney disease patients

Markus Ketteler and Jürgen Floege

in The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease

Second edition

Published on behalf of Oxford University Press

Published in print June 2010 | ISBN: 9780199559176
Published online November 2012 | e-ISBN: 9780191753350 | DOI: http://dx.doi.org/10.1093/med/9780199559176.003.019

Series: Oxford Clinical Nephrology Series

Clinical management of vascular and soft tissue calcifications in chronic kidney disease patients

Show Summary Details

Preview

Vascular and soft-tissue calcifications are not just a random process of passive calcium and phosphate precipitation, but involve active cellular processes influenced by the presence or absence of inhibitors and inducers. In this context, phosphate and calcium are among the key active inducers of cellular pro-calcifying pathomechanisms, especially in patients with advanced CKD. Additionally, the presence (or absence) and activity of calcification inhibitors may potently modify clinical calcification progression in CKD patients at risk. Cardiovascular calcification is amongst the strongest risk predictors of death in the CKD population, so appropriate management approaches, including phosphate lowering and avoidance of unreasonable calcium loads, are likely to improve outcomes. In the future, modifying vitamin K status, thiosulphate administration, or anti-inflammatory strategies may become additional tools in calcification-prone CKD individuals.

Chapter.  5092 words.  Illustrated.

Subjects: Rheumatology ; Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.